top of page
Partner With Us
We are engineering the future of human health through protein-centric biologics. Join our mission as a scientist, investor, or clinical partner.
Partnerships: info@proteocent.com
Science Quarter, Boston, MA 02110
News & Scientific Updates
OCT 24, 2026
Proteocent Announces Breakthrough in Bispecific Antibody Combinations for Solid Tumors
SEP 12, 2026
Pipeline Update: Immune Oncology Protein Combination PT-102 Enters Phase I Trials
AUG 05, 2026
Proteocent Founders Awarded Biotech Innovation Grant for Protein Stability Research
bottom of page